Circulating and Myocardial Cytokines Predict Cardiac Structural and Functional Improvement in Patients With Heart Failure Undergoing Mechanical Circulatory Support.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
19 10 2021
Historique:
pubmed: 2 10 2021
medline: 21 12 2021
entrez: 1 10 2021
Statut: ppublish

Résumé

Background Recent prospective multicenter data from patients with advanced heart failure demonstrated that left ventricular assist device (LVAD) support combined with standard heart failure medications, induced significant cardiac structural and functional improvement, leading to high rates of LVAD weaning in selected patients. We investigated whether preintervention myocardial and systemic inflammatory burden could help identify the subset of patients with advanced heart failure prone to LVAD-mediated cardiac improvement to guide patient selection, treatment, and monitoring. Methods and Results Ninety-three patients requiring durable LVAD were prospectively enrolled. Myocardial tissue and blood were acquired during LVAD implantation, for measurement of inflammatory markers. Cardiac structural and functional improvement was prospectively assessed via serial echocardiography. Eleven percent of the patients showed significant reverse remodeling following LVAD support (ie, responders). Circulating tumor necrosis factor alpha, interleukin (IL)-4, IL-5, IL-6, IL-7, IL-13, and interferon gamma were lower in responders, compared with nonresponders (

Identifiants

pubmed: 34595931
doi: 10.1161/JAHA.120.020238
pmc: PMC8751895
doi:

Substances chimiques

Biomarkers 0
Cytokines 0
Tumor Necrosis Factor-alpha 0
Interferon-gamma 82115-62-6

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e020238

Subventions

Organisme : NHLBI NIH HHS
ID : T32 HL007576
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL135121
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL132067
Pays : United States

Références

Circulation. 2007 May 15;115(19):2497-505
pubmed: 17485581
Mediators Inflamm. 2014;2014:281790
pubmed: 25132729
J Am Coll Cardiol. 2017 Mar 14;69(10):1286-1287
pubmed: 28279295
Heart Fail Rev. 2011 Jan;16(1):35-47
pubmed: 20407820
Circ Res. 2011 Apr 29;108(9):1122-32
pubmed: 21527742
Heart Fail Rev. 2018 Sep;23(5):733-758
pubmed: 29862462
Am J Pathol. 2007 Aug;171(2):463-72
pubmed: 17556594
N Engl J Med. 2006 Nov 2;355(18):1873-84
pubmed: 17079761
Circ Heart Fail. 2018 Nov;11(11):e005267
pubmed: 30571195
Circulation. 1999 Sep 14;100(11):1189-93
pubmed: 10484539
Eur J Heart Fail. 2007 May;9(5):525-30
pubmed: 17257894
J Am Coll Cardiol. 2013 May 14;61(19):1985-94
pubmed: 23500219
Circulation. 2008 Sep 30;118(14 Suppl):S94-105
pubmed: 18824777
Eur J Heart Fail. 2008 Sep;10(9):861-8
pubmed: 18768352
Circulation. 2005 Aug 30;112(9 Suppl):I46-50
pubmed: 16159864
Am J Physiol Heart Circ Physiol. 2019 Jan 1;316(1):H24-H34
pubmed: 30339498
JACC Basic Transl Sci. 2017 Jun;2(3):335-340
pubmed: 28736756
PLoS One. 2014 Mar 04;9(3):e90802
pubmed: 24594915
Circ Heart Fail. 2016 Jul;9(7):
pubmed: 27402861
J Am Soc Echocardiogr. 2005 Dec;18(12):1440-63
pubmed: 16376782
Am J Physiol Heart Circ Physiol. 2006 Jul;291(1):H106-13
pubmed: 16461369
Shock. 2004 Jan;21(1):26-30
pubmed: 14676680
J Heart Lung Transplant. 2000 Sep;19(9):819-24
pubmed: 11008069
J Am Coll Cardiol. 2016 Oct 18;68(16):1741-1752
pubmed: 27737740
Eur J Heart Fail. 2009 Oct;11(10):967-72
pubmed: 19789400
Can J Cardiol. 2011 May-Jun;27(3):358-62
pubmed: 21601774
Cytokine. 2005 Sep 21;31(6):405-14
pubmed: 16105741
Curr Atheroscler Rep. 2018 Sep 14;20(10):52
pubmed: 30218437
Open Heart. 2018 Apr 25;5(1):e000807
pubmed: 29713486
J Card Fail. 2010 Feb;16(2):99-105
pubmed: 20142020
Inflamm Res. 2020 Oct;69(10):975-988
pubmed: 32699989
Ann Thorac Surg. 2021 Mar;111(3):778-792
pubmed: 33465365
Circulation. 2017 Apr 25;135(17):1632-1645
pubmed: 28073805
Circulation. 2011 Feb 1;123(4):381-90
pubmed: 21242487
Circ Res. 2016 Jun 24;119(1):159-76
pubmed: 27340274
J Am Coll Cardiol. 2016 Oct 4;68(14):1540-53
pubmed: 27687196
J Mol Cell Cardiol. 2007 Sep;43(3):231-42
pubmed: 17651751
Circulation. 2005 Aug 30;112(9 Suppl):I57-64
pubmed: 16159866

Auteurs

Nikolaos A Diakos (NA)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.

Iosif Taleb (I)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.
University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Christos P Kyriakopoulos (CP)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.
University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Kevin S Shah (KS)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Hadi Javan (H)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.
University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Tyler J Richins (TJ)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.

Michael Y Yin (MY)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Chi-Gang Yen (CG)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Elizabeth Dranow (E)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Michael J Bonios (MJ)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Rami Alharethi (R)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Antigone G Koliopoulou (AG)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Mariam Taleb (M)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.

James C Fang (JC)

University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Craig H Selzman (CH)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.
University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Konstantinos Stellos (K)

Cardiovascular Research Centre Newcastle University & Cardiothoracic CentreNewcastle upon Tyne Hospitals Newcastle UK.

Stavros G Drakos (SG)

Nora Eccles Harrison Cardiovascular Research and Training InstituteUniversity of Utah Salt Lake City UT.
University of Utah Health and School of Medicine, Intermountain Medical Center, George E. Wahlen Department of Veterans Affairs Medical CenterU.T.A.H. (Utah Transplant Affiliated Hospitals) Cardiac Transplant Program Salt Lake City UT.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH